Welcome to  ISG Virtual TechXchange: Health Sciences event - an immersive, two-day event that explores the evolving healthcare and life-science ecosystem. From developing patient-centric approaches and strategies to put interoperability at the heart of your organization; utilizing emerging innovations to rapidly respond to shifts in patient and payer expectations, and leveraging the effects of pandemic-forced innovation, this is an event you can't afford to miss. ISG's Bob Krohn & Jenn Stein will set the stage for the day, before taking a look at the direction these two industries are heading.

One year on and where do we stand?  Innovation catalyzed by the pandemic dissolved traditional boundaries. Now, that same innovation is redefining what's possible and set the stage for what's to come. Before we spend the rest of the event looking forward, let's take a moment to realign. In this interactive roundtable discussion, ISG expert advisors share the following takeaways:

• What fundamental market shifts have we encountered in the last 12-months?
• Financial Health-Check - Cutting Costs for Digital or Operating Expenses
• What does the market look like for payers, providers, and solution partners?

Understanding how to prioritize, operationalize and embed emerging technologies in care delivery is a key concern for many healthcare organizations. This is further accelerated by changing healthcare consumer behaviour requiring organizations to accelerate their digital transformation journey. Here, leaders in payers, providers and Healthcare IT share their view on key trends shaping the industry and guiding their internal digital transformation initiatives. In addition, we discuss the imperatives of these key trends and the best practices for engagement between a Health IT and a Healthcare delivery organization for a meaningful and outcome oriented partnership.

These sessions provide demonstrations of innovative and cutting-edge technologies that are helping to shape the future of business.

Interoperability plays a key role in the future of health. Government regulations are making it a requirement leaving steadfast opposition no choice but to acquiesce. Interoperability drives connected care by collating genetic, environmental, patient-generated health data and existing health records to paint a holistic picture of an individual’s health. In short, its driving digital transformation and paving the way for a new future. In this session, ISG’s xx outlines the benefits, challenges, and the future of interoperability in Health Care and Life Sciences. 

Technology advancements, broad-based commercialization of wearables and sensors, and the impact of a global pandemic are proving to be pivotal in the shift towards decentralized clinical trials. The ability for remote, unobtrusive and real-time capture of patient data coupled with the need to reduce in-person contact is accelerating the life sciences industry’s interest in new approaches to clinical trials. This use of sensors and real-time data capture vastly improves the quality of clinical data with the potential to reduce site queries and monitoring visits. There is also unprecedented accessibility to vast volumes of patient data – and the ability to apply artificial intelligence and machine learning in the analysis of that data – all powering new safety and clinical insights. In this session, Cognizant will explore current state of technology, the impact of regulatory oversight, and readiness of the industry to drive necessary changes.

These sessions provide demonstrations of innovative and cutting-edge technologies that are helping to shape the future of business.

The healthcare industry’s digital infrastructure is at a disruptive inflection point as two major market forces converge:  1) COVID has highlighted that legacy infrastructure is not nimble enough to quickly address changing needs; and 2) the drive by government and commercial players to transition to interoperability and FHIR standards on an expedited basis. A common theme is arising as this new digital infrastructure is being built: Deep clinical expertise and knowledge needs to be built into these new ecosystems up front, rather than as an afterthought. In this session, hear from a leader in clinical content data science and analytics on this new landscape. 

Topics include:

• Value based care and incorporating timely, relevant, and actionable measures analytics into healthcare workflows 
• Identification and prediction of gaps in care with the ability to intervene in care delivery
• The critical nature of including clinical content expertise in the development of AI/ML applications that solve real-world problems
• The importance of bringing “science” back into data science to properly remove bias and achieve better results
• Bridging the divide between the data, technology, and decision makers 
   

While mergers, acquisitions, and divestitures (M, A & D) offer multiple advantages like achieving economies of scale, the transactions that occur around these deals are extremely complex. Based on our experience, typically 1% of the revenue is at risk.

Genpact Regulatory Affairs, a leader in life sciences Global Regulatory Services, has deep experience helping clients prepare for Day One readiness. We enable a smooth transition that cuts across Regulatory, Supply Chain, and Quality to ensure continuity of service, while minimizing supply disruption and maintaining compliance.

Join our Genpact Regulatory Affairs experts as they share a unique, industry-leading perspective on how to manage M, A & D challenges by bringing the Regulatory, Quality, and Supply functions together.

In this presentation, you’ll get insights on:

• Maintaining global compliance during a large-scale transformation
• Accelerating your integration/divestiture/join venture timelines via methodologies, accelerators and cloud-based solutions
• Minimizing disruption in your supply chain